$14.50
0.13[0.90%]
At close: Apr 26
$14.50
0[0.00%]
After Hours: 4:04PM EDT
Macrogenics
(NASDAQ:MGNX)Latest News for Macrogenics Stock (NASDAQ:MGNX)
Macrogenics Stock (NASDAQ: MGNX)
Categories: All
Tuesday, April 09, 2024
Friday, April 05, 2024
Thursday, April 04, 2024
- MacroGenics Analyst Impressed By Improved Safety Profile From Prostate Cancer CandidateVandana Singh - Apr 4, 2024, 2:15PM
- Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Apr 4, 2024, 1:21PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Apr 4, 2024, 12:31PM
- The Latest Analyst Ratings For MacrogenicsBenzinga Insights - Apr 4, 2024, 12:01PM
- JMP Securities Reiterates Market Outperform on MacrogenicsBenzinga Newsdesk - Apr 4, 2024, 8:56AM
- MacroGenics shares are trading higher. The stock initially fell after the company provided an update and early interim safety data on its Phase 2 TAMARACK study and has since reversed.Benzinga Newsdesk - Apr 4, 2024, 7:44AM
- Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market SessionAvi Kapoor - Apr 4, 2024, 5:18AM
Wednesday, April 03, 2024
- MacroGenics shares are trading lower after the company announced TAMARACK study data will not be presented at the ASCO Annual Meeting.Benzinga Newsdesk - Apr 3, 2024, 4:40PM
- MacroGenics Says TAMARACK Study Data Will Not Be Presented At ASCO Annual Meeting But Co. Intends To Maintain Previously Disclosed Plan To Share Further TAMARACK Interim Data By End Of MayBenzinga Newsdesk - Apr 3, 2024, 4:33PM
Monday, March 11, 2024
- Citigroup Maintains Buy on Macrogenics, Raises Price Target to $25Benzinga Newsdesk - Mar 11, 2024, 11:59AM
- JMP Securities Maintains Outperform on Macrogenics, Raises Price Target to $22Benzinga Newsdesk - Mar 11, 2024, 7:23AM
- HC Wainwright & Co. Maintains Neutral on Macrogenics, Raises Price Target to $16Benzinga Newsdesk - Mar 11, 2024, 6:43AM
Friday, March 08, 2024
- BMO Capital Maintains Outperform on Macrogenics, Raises Price Target to $24Benzinga Newsdesk - Mar 8, 2024, 11:22AM
- Stifel Maintains Buy on Macrogenics, Raises Price Target to $29Benzinga Newsdesk - Mar 8, 2024, 10:42AM
- MacroGenics shares are trading lower after the company reported Q4 Results.Benzinga Newsdesk - Mar 8, 2024, 7:04AM
- Barclays Maintains Overweight on Macrogenics, Raises Price Target to $25Benzinga Newsdesk - Mar 8, 2024, 6:06AM
Thursday, March 07, 2024
- MacroGenics shares are trading lower after the company reported a year-over-year decrease in Q4 revenue results.Benzinga Newsdesk - Mar 7, 2024, 5:04PM
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Mar 7, 2024, 4:31PM
- Macrogenics: Q4 Earnings InsightsBenzinga Insights - Mar 7, 2024, 4:15PM
- Macrogenics Q4 2023 GAAP EPS $(0.750), Sales $10.720M Down From $73.099M YoYBenzinga Newsdesk - Mar 7, 2024, 4:14PM
- Earnings Scheduled For March 7, 2024Benzinga Insights - Mar 7, 2024, 4:49AM
Wednesday, March 06, 2024
Monday, March 04, 2024
Thursday, February 29, 2024
Monday, February 26, 2024
Wednesday, February 14, 2024
Wednesday, January 24, 2024
Friday, January 19, 2024
Wednesday, December 20, 2023
- Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Dec 20, 2023, 1:16PM
- MacroGenics shares are trading higher after Citigroup upgraded the stock from Neutral to Buy and raised its price target from $7 to $13.Benzinga Newsdesk - Dec 20, 2023, 10:51AM
- Toro Posts Upbeat Results, Joins Clear Channel Outdoor, Marathon Digital And Other Big Stocks Moving Higher On WednesdayAvi Kapoor - Dec 20, 2023, 10:10AM
- Top 4 Health Care Stocks That May Crash This MonthAvi Kapoor - Dec 20, 2023, 8:31AM
- EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For WednesdayAvi Kapoor - Dec 20, 2023, 7:50AM
- Forecasting The Future: 4 Analyst Projections For MacrogenicsBenzinga Insights - Dec 20, 2023, 7:00AM
- Citigroup Upgrades Macrogenics to Buy, Raises Price Target to $13Benzinga Newsdesk - Dec 20, 2023, 4:20AM
Monday, November 27, 2023
Monday, November 13, 2023
Tuesday, November 07, 2023
- Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Nov 7, 2023, 1:10PM
- MacroGenics shares are trading higher after the company reported Q3 financial results. Following earnings, Guggenheim upgraded the stock from Neutral to Buy and announced a $12 price target.Benzinga Newsdesk - Nov 7, 2023, 12:29PM
- Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On TuesdayLisa Levin - Nov 7, 2023, 10:54AM
- Guggenheim Upgrades Macrogenics to Buy, Announces $12 Price TargetBenzinga Newsdesk - Nov 7, 2023, 7:38AM